InnovationRx: FDA OKs Abbott’s New Pacemaker

  • 📰 Forbes
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 53%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

InnovationRx: FDA OKs Abbott’s New Pacemaker by katiedjennings

Masimo founder and CEO Joe Kiani, photographed at Masimo's headquarters, Irvine, CA.Joe Kiani, the founder and CEO of Masimo, has spent $60 million fighting the nearly $3 trillion company in court over the Apple Watch, but he’s also facing a boardroom battle over his own consumer tech push. These legal fights are coming as Kiani, whoestimates is worth $1.2 billion, is starting to enter the consumer space with watches and other wearables.

from the FDA for human use in minor cuts and lacerations. Previously, the product had been approved for veterinary use. Cresilon CEO Joe Landolina was on the 2023 Forbes Under 30 Healthcare list.a $65 million Series A round to expand its medical scanning technology throughout Europe. The company says the 10-minute scans, which cost $270 are currently only offered in Stockholm, can help doctors detect skin cancer and cardiovascular disease earlier, among other health issues.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

InnovationRx: FDA OKs Abbott’s New PacemakerInnovationRx is your weekly digest of healthcare news. Sign up!
Source: ForbesTech - 🏆 318. / 59 Read more »